545 related articles for article (PubMed ID: 2414431)
1. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
Messing RO; Carpenter CL; Greenberg DA
J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
[TBL] [Abstract][Full Text] [Related]
2. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
[TBL] [Abstract][Full Text] [Related]
3. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
Boles RG; Yamamura HI; Schoemaker H; Roeske WR
J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261
[TBL] [Abstract][Full Text] [Related]
4. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
[TBL] [Abstract][Full Text] [Related]
5. Effects of Ca++ on [3H]diltiazem binding and its allosteric interaction with dihydropyridine calcium channel binding sites in the rat cortex.
Schoemaker H; Langer SZ
J Pharmacol Exp Ther; 1989 Feb; 248(2):710-5. PubMed ID: 2537412
[TBL] [Abstract][Full Text] [Related]
6. Dihydropyridine binding and calcium channel function in clonal rat adrenal medullary tumor cells.
Kunze DL; Hamilton SL; Hawkes MJ; Brown AM
Mol Pharmacol; 1987 Apr; 31(4):401-9. PubMed ID: 2437436
[TBL] [Abstract][Full Text] [Related]
7. Molecular approach to the calcium channel.
Glossmann H; Ferry DR; Goll A; Linn T
Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
[TBL] [Abstract][Full Text] [Related]
8. Allosteric modulation by diltiazem and verapamil of [3H]nitrendipine binding to calcium channel sites in rat brain.
Schoemaker H; Boles RG; Roeske WR; Yamamura HI
Proc West Pharmacol Soc; 1983; 26():219-24. PubMed ID: 6310626
[No Abstract] [Full Text] [Related]
9. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength.
Bellemann P; Ferry D; Lübbecke F; Glossmann H
Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
Janis RA; Sarmiento JG; Maurer SC; Bolger GT; Triggle DJ
J Pharmacol Exp Ther; 1984 Oct; 231(1):8-15. PubMed ID: 6208356
[TBL] [Abstract][Full Text] [Related]
11. Phenytoin interacts with calcium channels in brain membranes.
Greenberg DA; Cooper EC; Carpenter CL
Ann Neurol; 1984 Nov; 16(5):616-7. PubMed ID: 6095733
[TBL] [Abstract][Full Text] [Related]
12. Effects of Ca2+ channel blockers on Ca2+ translocation across synaptosomal membranes.
Carvalho CA; Coutinho OP; Carvalho AP
J Neurochem; 1986 Dec; 47(6):1774-84. PubMed ID: 2430061
[TBL] [Abstract][Full Text] [Related]
13. A calcium antagonist drug binding site in skeletal muscle sarcoplasmic reticulum: evidence for a calcium channel.
Fairhurst AS; Thayer SA; Colker JE; Beatty DA
Life Sci; 1983 Mar; 32(12):1331-9. PubMed ID: 6300579
[TBL] [Abstract][Full Text] [Related]
14. High affinity binding sites for [3H]-nitrendipine in rabbit uterine smooth muscle.
Miller WC; Moore JB
Life Sci; 1984 Apr; 34(18):1717-24. PubMed ID: 6727544
[TBL] [Abstract][Full Text] [Related]
15. Calcium antagonists High-affinity binding and inhibition of calcium transport in a clonal cell line.
Toll L
J Biol Chem; 1982 Nov; 257(22):13189-92. PubMed ID: 6292179
[TBL] [Abstract][Full Text] [Related]
16. Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine.
Gould RJ; Murphy KM; Snyder SH
Mol Pharmacol; 1984 Mar; 25(2):235-41. PubMed ID: 6422256
[TBL] [Abstract][Full Text] [Related]
17. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
[TBL] [Abstract][Full Text] [Related]
18. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
Zahradníková A; Minarovic I; Zahradník I
J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
[TBL] [Abstract][Full Text] [Related]
19. Effect of calcium antagonist drugs on calcium currents in mammalian skeletal muscle fibers.
Walsh KB; Bryant SH; Schwartz A
J Pharmacol Exp Ther; 1986 Feb; 236(2):403-7. PubMed ID: 2418195
[TBL] [Abstract][Full Text] [Related]
20. Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells.
Greenberg DA; Carpenter CL; Messing RO
J Pharmacol Exp Ther; 1986 Sep; 238(3):1021-7. PubMed ID: 2427685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
